Heidelberg Pharma Forecast, price target & analysts
€2.64
0.76%
yesterday
Xetra,
Mar 21, 05:36 pm CET
Heidelberg Pharma Target price 2025 - Analyst rating & recommendation
Powered by
Heidelberg Pharma Classifications & Recommendation:
Buy
100%
Heidelberg Pharma Price Target
| Target Price | €11.90 |
| Price | €2.64 |
| Potential |
350.76%
register free of charge
|
| Number of Estimates | 1 |
|
1 Analyst has issued a Heidelberg Pharma price target 2026.
The average Heidelberg Pharma target price is €11.90.
This is
350.76%
register free of charge
|
|
| A rating was issued by 1 analysts: 1 Analysts recommend Heidelberg Pharma to buy, 0 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Heidelberg Pharma stock has an average upside potential 2026 of
350.76%
register free of charge
|
Sales and Margin forecast 2024, 2025 & 2026
Create a premium account to unlock analyst estimates.
Learn more
Powered by
| Nov '23 |
2024 Estimates |
|
|---|---|---|
| Revenue Million € | 9.86 | 11.50 |
| 46.73% | 16.63% | |
| EBITDA Margin | -270.18% | -162.61% |
| 182.55% | 39.81% |
1 Analyst has issued a sales forecast Heidelberg Pharma 2024 . The average Heidelberg Pharma sales estimate is
€11.5m
Unlock
35.77%
higher
Unlock
€11.5m
35.77%
Unlock
€11.5m
35.77%
Unlock
This results in the following potential growth metrics:
1 Analyst has issued an EBITDA forecast Heidelberg Pharma 2024 . The average Heidelberg Pharma EBITDA estimate is
€-18.7m
Unlock
8.02%
higher
Unlock
€-18.7m
8.02%
Unlock
€-18.7m
8.02%
Unlock
This results in the following potential growth metrics and future EBITDA Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 & 2026
Create a premium account to unlock analyst estimates.
Learn more
Powered by
| Nov '23 |
2024 Estimates |
|
|---|---|---|
| EV/Sales | 9.37 |
Current Heidelberg Pharma Upgrades & Downgrades
Create a Premium account to unlock Upgrades/Downgrades.
Learn more
| Analyst | Rating | Action | Date |
|---|---|---|---|
| PARETO SECURITIES AS |
Locked
➜
Locked
|
Locked | Oct 09 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
PARETO SECURITIES AS:
Locked
➜
Locked
|
Oct 09 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
